Piramal Pharma Ltd’s Post

Discover what our CEO & Whole time director-Mr. Nikhil Chopra, JB Pharma has to say on how has the Indian Pharma Sector risen to the top with Chronic Care, Tech Drive, and Global Ambitions. Read the full story - https://lnkd.in/da-dmm_F Nikhil Chopra #JBPharma #GoodPeopleforGoodHealth

Chiesi Group really are at the forefront of patient centricity in the pharma industry, whilst also being cognisant of site burden. I know this from personal experience and from Marisa Minetti & Ylenia Paleari, PhD, PgCert presentation at #PatientsEU2024 around the implementation of Decentralized approaches to clinical trials. #patientfirst #clinicaltrials

🚀 Unveiling the Future Direction of Biopharma Partnerships and Digital Health! 🌐🧬 🔍 Did you know? In 2021, the top 25 biopharma companies led the charge in Digital Health partnerships, holding a staggering 57% of global collaborations. Fast forward to 2023, and there's been a significant shift. These leading companies' share has dipped to 45%, signaling a fascinating transformation in the landscape. 📈 Galen Growth proudly unveils its third annual Pharmaceutical Innovation Index, spotlighting the movers and shakers in the global Digital Health innovation arena. 🏅 This year, our methodology zeroes in on a pivotal industry pain point: drug development efficiency. 🎯 We've refined our focus to partnerships formed within the last three years, recognizing the dynamic evolution of biopharma Digital Health strategies over the past decade. 🔗 Curious to delve deeper into the insights and trends? 📊 Download the report for free and discover the cutting-edge collaborations shaping the future of healthcare! 💡💊 #digitalhealth #pharmatrends #healthcareevolution #galengrowth #downloadnow 📥

Pharmarack presents “PharmaMonitor”, a monthly webinar aimed towards topics of discussion that provide new perspectives on Healthcare dynamics in India In this curated webinar discussion, you'll find a wealth of knowledge equipped with Pharma Industry perspectives that will equip you with the intelligence needed to make informed decisions in your business calls. Stay ahead of the curve with our insights. Mark your calendars for the next edition of Pharma Monitor. Don't miss out! #PharmaMonitor #MarketTrends #PharmaceuticalIndustry #Pharmarack #Healthcare

The Indian Pharma Industry is a healthy sector showing a 5-year value CAGR of 8%. While there are many players who have made it big here, there are many more who are striving to make the best of the opportunity. Going solo may not be the best way to do this.   In our May’24 volume of IPM Diaries, we have discussed about the Strategic Partnerships in the Indian Pharma Industry with relevant Business Cases. The Study is divided into three sections: 1. Attractiveness of the Indian Healthcare market along with types of Strategic Partnerships 2. Business Cases 3. Challenges in Strategic Partnerships  

Dive into the latest Economic Times (ET Insights) feature of Mr.Nikhil Chopra, CEO - JB Pharma, to know more about how Indian Pharma Industry is contributing towards shaping global healthcare needs today! Nikhil Chopra , Sushree Mishra, The Economic Times, ET Edge , The Times Group presents ET Now Global Business Summit #JBPharma #GoodPeopleforGoodHealth #ETInsights

Culture, capability development and robust governance cited as success factors for healthcare and pharma sectors growth.

ZS insights on the forces shaping pharma’s 2024 outlook - the Five Key take aways are as follows:   1.      Building resilience through scientific and portfolio innovation 2.      Creating stability through near-term efficiencies and cost optimization 3.      Maintaining relevance by reimagining customer engagement 4.      Fostering partnership through deeper relationships across the healthcare ecosystem 5.      Failure to evolve will compound pharma’s public trust deficit   “While there will always be a market for new, innovative medicines, failure to evolve will limit these innovations’ reach and impact. Evolution will mean prioritizing customers, understanding (and responding to) their needs and continuously driving value across an increasingly diffuse healthcare ecosystem. Despite headwinds, 2024 could mark the start of a pharmaceutical renaissance that sees the industry become the true agents of a healthier, more connected world beyond medicine”.

🚀 Exciting Milestone Alert for the MedTech & Pharmaceutical Industry! I'm beyond excited to share some major news with you all! After a journey filled with intense data gathering and analysis, our dedicated team at Vamstar has hit a monumental milestone. We've now got an incredible opportunity to bring something truly groundbreaking to the MedTech and Pharmaceutical industries. With pricing challenges significantly impacting these sectors—evident in the steep decline in net margins by over 15% over the last decade and the rising costs of operations—our breakthrough couldn't have come at a more crucial time. We're witnessing a transformative shift in our industry, with a strong move towards more tighter engagement with healthcare professionals (HCPs) and even extending to home environment (Care moving to home). This necessary evolution, however, suggests that the expenses involved in doing business are set to climb even higher (further eroding net margins). Now more than ever, a deep dive into the intricacies of pricing and portfolios, coupled with strategies aimed at fostering both growth and sustainability, is absolutely essential. Yet, this is where many pricing teams hit a roadblock—due to a stark lack of vital data, insights, and the right tools. But that's about to change. Enter Vamstar's Pricing Co-Pilot: https://lnkd.in/e5JvmxZV By harnessing the power of artificial intelligence, this trailblazing tool is set to revolutionise how we tackle pricing in our field. It's meticulously crafted to bridge the gap, offering the much-needed insights, data, and tools that have been missing from the equation. With Pricing Co-Pilot, informed decision-making becomes faster and more effective, marking a significant leap forward in our approach to pricing. Let's dive into this new era together! 📅 Ready to revolutionise your pricing strategy? For a detailed demo or insights about various case studies of what Pricing Co-Pilot can do for your organisation, or if you're simply eager to learn more, please feel free to book a session with me or just drop a "yes" in the comments below. Let's navigate the future of MedTech and Pharmaceutical pricing together! #MedTech #Pharmaceuticals #PricingStrategy #Innovation #AI #Vamstar #BusinessGrowth #Sustainability

Our fourth quarter market data update for the MedTech industry is out.